药品名称HMS
申请号016624产品号003
活性成分MEDRYSONE市场状态停止上市
剂型或给药途径SUSPENSION;OPHTHALMIC规格1%
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构ALLERGAN PHARMACEUTICAL
化学类型New molecular entity (NME)审评分类Standard review drug
与本品相关的专利信息(来自橙皮书Orange Book)
专利号专利过期日是否化合物专利是否产品专利专利用途代码专利下载
历史专利信息
与本品相关的市场独占权保护信息
独占权代码失效日期
历史市场独占权保护信息
与药品注册相关的信息
申请号修订号审批结论公开文档类型文档创建时间获取文档
016624041APLetter2002/08/23下载
016624041APLabel2002/08/23下载
药品注册审批历史信息
申请号修订号审批结论审批日期审批内容
016624043AP2002/04/12Control Supplement
016624042AP2001/12/04Manufacturing Change or Addition
016624041AP2002/08/23Manufacturing Change or Addition
016624040AP2001/04/12Manufacturing Change or Addition
016624039AP2000/10/02Manufacturing Change or Addition
016624038AP1998/09/28Control Supplement
016624037AP1996/12/05Control Supplement
016624036AP1995/08/03Control Supplement
016624035AP1993/08/13Control Supplement
016624034AP1989/10/17Manufacturing Change or Addition
016624033AP1989/03/30Control Supplement
016624032AP1989/11/07Manufacturing Change or Addition
016624031AP1986/07/18Control Supplement
016624027AP1982/05/12Manufacturing Change or Addition
016624026AP1982/09/17Manufacturing Change or Addition
016624025AP1980/05/22Manufacturing Change or Addition
016624024AP1979/10/02Control Supplement
016624022AP1976/10/27Labeling Revision
016624021AP1976/10/27Labeling Revision
016624020AP1976/10/27Labeling Revision
016624018AP1975/12/11Control Supplement
016624017AP1975/12/11Labeling Revision
016624016AP1975/05/27Labeling Revision
016624015AP1976/10/27Control Supplement
016624014AP1976/04/07Control Supplement
016624013AP1976/10/27Labeling Revision
016624012AP1974/11/25Control Supplement
016624011AP1974/11/25Labeling Revision
016624009AP1975/06/26Supplement
016624000AP1969/11/28Approval